Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B L Lum

Showing results (31-40 of 53) with videos related to

Pageof 6
Sort By:
The Journal of Urology|January 1, 1992
Transitional cell carcinoma of the prostate in patients undergoing radical cystoprostatectomyJ H Reese, F S Freiha, A B Gelb, et al.
Psychopharmacology Bulletin|May 2, 1998
Risperidone: clinical outcome predictors and cost-effectiveness in a naturalistic settingP R Finley, B R Sommer, J L Corbitt, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1997
Modulation and prevention of multidrug resistance by inhibitors of P-glycoproteinB I Sikic, G A Fisher, B L Lum, et al.
Pharmacotherapy|November 5, 1997
Validation of a limited sampling model to determine etoposide area under the curveB L Lum, K J Lane, T W Synold, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 15, 2001
A phase I trial of doxorubicin, paclitaxel, and valspodar (PSC 833), a modulator of multidrug resistanceR Advani, G A Fisher, B L Lum, et al.
Cancer|March 15, 1991
The use of probenecid as a chemoprotector against cisplatin nephrotoxicityC Jacobs, S Kaubisch, J Halsey, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1987
Superficial bladder cancer: the primacy of grade in the development of invasive diseaseF M Torti, B L Lum, D Aston, et al.
DICP : the Annals of Pharmacotherapy|February 1, 1989
A clinical pharmacy-oriented drug surveillance network: results of a nationwide antibiotic utilization review of bacterial pneumonia--1987T H Grasela, J J Schentag, S J Boekenoogen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 30, 2005
A phase I trial of liposomal doxorubicin, paclitaxel and valspodar (PSC-833), an inhibitor of multidrug resistanceR Advani, B L Lum, G A Fisher, et al.
International Journal of Radiation Oncology, Biology, Physics|November 8, 2001
Long-term results of irradiation for patients with progressive Graves' ophthalmopathyS D Marquez, B L Lum, I R McDougall, et al.
Pageof 6

Showing results (31-40 of 53) with videos related to

Sort By:
Pageof 6
The Journal of Urology|January 1, 1992
Transitional cell carcinoma of the prostate in patients undergoing radical cystoprostatectomyJ H Reese, F S Freiha, A B Gelb, et al.
Psychopharmacology Bulletin|May 2, 1998
Risperidone: clinical outcome predictors and cost-effectiveness in a naturalistic settingP R Finley, B R Sommer, J L Corbitt, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1997
Modulation and prevention of multidrug resistance by inhibitors of P-glycoproteinB I Sikic, G A Fisher, B L Lum, et al.
Pharmacotherapy|November 5, 1997
Validation of a limited sampling model to determine etoposide area under the curveB L Lum, K J Lane, T W Synold, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 15, 2001
A phase I trial of doxorubicin, paclitaxel, and valspodar (PSC 833), a modulator of multidrug resistanceR Advani, G A Fisher, B L Lum, et al.
Cancer|March 15, 1991
The use of probenecid as a chemoprotector against cisplatin nephrotoxicityC Jacobs, S Kaubisch, J Halsey, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1987
Superficial bladder cancer: the primacy of grade in the development of invasive diseaseF M Torti, B L Lum, D Aston, et al.
DICP : the Annals of Pharmacotherapy|February 1, 1989
A clinical pharmacy-oriented drug surveillance network: results of a nationwide antibiotic utilization review of bacterial pneumonia--1987T H Grasela, J J Schentag, S J Boekenoogen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 30, 2005
A phase I trial of liposomal doxorubicin, paclitaxel and valspodar (PSC-833), an inhibitor of multidrug resistanceR Advani, B L Lum, G A Fisher, et al.
International Journal of Radiation Oncology, Biology, Physics|November 8, 2001
Long-term results of irradiation for patients with progressive Graves' ophthalmopathyS D Marquez, B L Lum, I R McDougall, et al.
Pageof 6